
|Podcasts|September 21, 2021
Dr. Allaway on the increased efficiency of transperineal biopsies
Author(s)Urology Times staff
“We need to do a better job sampling the prostate,” says Matthew J. Allaway, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Matthew J. Allaway, MD. He discusses how his new technology, The PrecisionPoint Transperineal Access System, is used for detecting prostate cancer in patients. Matthew J. Allaway, MD, is the founder and president of Perinealogic and a urologist and managing partner at Urology Associates, Cumberland, Maryland.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
3
Doublet or triplet? Urologists weighs in on mCSPC options
4
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
5










